HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Figures Only Full Text All Versions of this Article: 2313030676v1 231/3/711    most recent Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Haider, M. A. Articles by Lockwood, G. Search for Related Content PubMed PubMed Citation Articles by Haider, M. A. Articles by Lockwood, G.

Chemical Shift MR Imaging of Hyperattenuating (>10 HU) Adrenal Masses: Does It Still Have a Role?¹

¹ From the Joint Department of Medical Imaging, University Health Network and Mount Sinai Hospital, University of Toronto, 610 University Ave, Toronto, ON, Canada M5G 2M9 (M.A.H., S.G., K.J.); and Department of Biostatistics, University Health Network and Princess Margaret Hospital, Toronto, Ontario, Canada (G.L.). Received April 28, 2003; revision requested July 9; final revision received September 23; accepted November 17. Address correspondence to M.A.H.

PURPOSE: To evaluate chemical shift magnetic resonance (MR) imaging for the characterization of hyperattenuating adrenal masses.

MATERIALS AND METHODS: Adrenal MR images obtained from January 1998 to February 2003 were reviewed. Patients were excluded if they did not undergo unenhanced computed tomography or did not have an adrenal mass with attenuation higher than 10 HU, adequate follow-up, or pathologic diagnosis for use as a reference standard. A diagnosis of adenoma required at least 24 weeks of stability on images. Thirty-eight masses in 36 patients were identified (27 adenomas, nine metastases, one adrenocortical oncocytoma, and one pheochromocytoma). Signal intensity (SI) decrease between in-phase and opposed-phase MR images was measured for the entire mass and normalized to the renal parenchymal SI. In 21 of 36 (58%) patients, dual-echo single–breath-hold MR imaging was used to eliminate misregistration.

RESULTS: The attenuation of 61% (23 of 38) of all masses and 70% (19 of 27) of adenomas was 10–30 HU. With a threshold of 20% SI decrease, the sensitivity of chemical shift MR imaging for hyperattenuating adenoma was 67% (18 of 27 masses). When considering masses with attenuation of 10–30 HU, the sensitivity for adenoma was 89% (17 of 19 masses) and remained reasonable at 75% (six of eight masses) for adenomas with attenuation of 20–30 HU. Only one adenoma with attenuation higher than 30 HU had SI decrease of more than 20%. Specificity for diagnosis of adenoma was 100% (11 of 11).

CONCLUSION: In certain circumstances, chemical shift MR imaging is a reasonable second imaging test for further characterization of a hyperattenuating adrenal mass.

© RSNA, 2004

Index terms: Adrenal gland, CT, 86.12112, 86.12115 • Adrenal gland, MR, 86.121411, 86.121414 • Adrenal gland, neoplasms, 86.317, 86.33 • Computed tomography (CT), phase imaging • Magnetic resonance (MR), chemical shift, 86.121414 • Pheochromocytoma, 86.328

This article has been cited by other articles:

				G. W. L. Boland, M. A. Blake, P. F. Hahn, and W. W. Mayo-Smith Incidental Adrenal Lesions: Principles, Techniques, and Algorithms for Imaging Characterization Radiology, December 1, 2008; 249(3): 756 - 775. [Abstract] [Full Text] [PDF]

				L. M. Ho, E. K. Paulson, M. J. Brady, T. Z. Wong, and S. T. Schindera Lipid-Poor Adenomas on Unenhanced CT: Does Histogram Analysis Increase Sensitivity Compared with a Mean Attenuation Threshold? Am. J. Roentgenol., July 1, 2008; 191(1): 234 - 238. [Abstract] [Full Text] [PDF]

				S. T. Schindera, B. J. Soher, D. M. Delong, B. M. Dale, and E. M. Merkle Effect of Echo Time Pair Selection on Quantitative Analysis for Adrenal Tumor Characterization with In-Phase and Opposed-Phase MR Imaging: Initial Experience Radiology, July 1, 2008; 248(1): 140 - 147. [Abstract] [Full Text] [PDF]

				J. F. Faria, S. M. Goldman, J. Szejnfeld, H. Melo, C. Kater, P. Kenney, M. P. Huayllas, G. Demarchi, V. V. Francisco, C. Andreoni, et al. Adrenal Masses: Characterization with in Vivo Proton MR Spectroscopy Initial Experience Radiology, December 1, 2007; 245(3): 788 - 797. [Abstract] [Full Text] [PDF]

				B. K. Park, C. K. Kim, B. Kim, and J. H. Lee Comparison of Delayed Enhanced CT and Chemical Shift MR for Evaluating Hyperattenuating Incidental Adrenal Masses Radiology, June 1, 2007; 243(3): 760 - 765. [Abstract] [Full Text] [PDF]

				K. S. Jhaveri, F. Wong, S. Ghai, and M. A. Haider Comparison of CT histogram analysis and chemical shift MRI in the characterization of indeterminate adrenal nodules. Am. J. Roentgenol., November 1, 2006; 187(5): 1303 - 1308. [Abstract] [Full Text] [PDF]

				S. Chong, K. S. Lee, H. Y. Kim, Y. K. Kim, B.-T. Kim, M. J. Chung, C. A Yi, and G. Y. Kwon Integrated PET-CT for the Characterization of Adrenal Gland Lesions in Cancer Patients: Diagnostic Efficacy and Interpretation Pitfalls RadioGraphics, November 1, 2006; 26(6): 1811 - 1824. [Abstract] [Full Text] [PDF]

				S. H. Kim, J. M. Lee, J. K. Han, J. Y. Lee, K. H. Lee, C. J. Han, J. Y. Jo, N.-J. Yi, K.-S. Suh, K.-S. Shin, et al. Hepatic Macrosteatosis: Predicting Appropriateness of Liver Donation by Using MR Imaging--Correlation with Histopathologic Findings Radiology, July 1, 2006; 240(1): 116 - 129. [Abstract] [Full Text] [PDF]

				J. K. Kim, S. H. Kim, Y. J. Jang, H. Ahn, C.-S. Kim, H. Park, J. W. Lee, S. Kim, and K.-S. Cho Renal Angiomyolipoma with Minimal Fat: Differentiation from Other Neoplasms at Double-Echo Chemical Shift FLASH MR Imaging Radiology, April 1, 2006; 239(1): 174 - 180. [Abstract] [Full Text] [PDF]

				M. A. Blake, J. M. A. Slattery, M. K. Kalra, E. F. Halpern, A. J. Fischman, P. R. Mueller, and G. W. Boland Adrenal Lesions: Characterization with Fused PET/CT Image in Patients with Proved or Suspected Malignancy--Initial Experience Radiology, March 1, 2006; 238(3): 970 - 977. [Abstract] [Full Text] [PDF]

				U. Metser, E. Miller, H. Lerman, G. Lievshitz, S. Avital, and E. Even-Sapir 18F-FDG PET/CT in the Evaluation of Adrenal Masses J. Nucl. Med., January 1, 2006; 47(1): 32 - 37. [Abstract] [Full Text] [PDF]

				G. Savci, Z. Yazici, N. Sahin, S. Akgoz, and E. Tuncel Value of Chemical Shift Subtraction MRI in Characterization of Adrenal Masses Am. J. Roentgenol., January 1, 2006; 186(1): 130 - 135. [Abstract] [Full Text] [PDF]

				M. A. Blake, M. K. Kalra, A. T. Sweeney, B. C. Lucey, M. M. Maher, D. V. Sahani, E. F. Halpern, P. R. Mueller, P. F. Hahn, and G. W. Boland Distinguishing Benign from Malignant Adrenal Masses: Multi-Detector Row CT Protocol with 10-Minute Delay Radiology, December 21, 2005; (2005) 2382041514. [Abstract] [Full Text]

				J. M. Pereira, C. B. Sirlin, P. S. Pinto, and G. Casola CT and MR Imaging of Extrahepatic Fatty Masses of the Abdomen and Pelvis: Techniques, Diagnosis, Differential Diagnosis, and Pitfalls RadioGraphics, January 1, 2005; 25(1): 69 - 85. [Abstract] [Full Text] [PDF]